Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,219 public trials 2,045 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Phase 1 Study of Oral TP-1454

NCT04328740

Conditions
Advanced Solid Tumor, Anal Cancer, Anus Diseases, +12 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Southern California - Norris Cancer Center and Hoag Memorial Hospital Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
View Trial Details
Completed

A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma

NCT02699606

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +33 more
Locations
  • Beijing, China
  • Harbin, China
  • Nanjing, China
  • Seoul, South Korea
View Trial Details
Completed

A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer

NCT04468607

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • City of Hope Duarte, California, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • Clinica Universitaria de Navarra Pamplona, Navarre, Spain
View Trial Details
Completed

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

NCT03428958

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +13 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details

Related conditions